gamma secretase inhibitor studied anticancer targeting gamma secretase inhibits notch signaling upregulated many forms drug initially developed roche treatment alzheimers disease current research focuses production halted began phase ii clinical trials performed phase iii trials yet phase ii studies investigated use ovarian renal cell carcinoma patients unsuccessful antivegf metastatic pancreatic advanced brain relapsed nonsmall cell lung planned clinical trials terminated drug became